Banner Backdrop

Mastering the Classics With Dr Gillman: Unlocking the Potential of MAOIs and TCAs in Modern Psychiatry

academy-maoi-background

Download Certificates Download Certificates

About The Course


Unlock the potential of MAOIs and TCAs by enhancing your understanding and application of MAOI antidepressants in modern psychiatric practice. This course explores the appropriate use and management of MAOIs and TCAs and guides you in identifying suitable patients for these medications. Learn the different types of MAOI and when to use them in managing depression, and recognize the absolute and relative contraindications for these medications.

What You'll Learn


  • Develop an understanding of the clinical application of MAOIs and TCAs in modern psychiatry practice.
  • Identify patients who are good candidates for TCAs and gaining insights into when to introduce these medications
  • Compare the mechanism of action of MAOIs to SSRI, SNRI and TCAs
  • Gain knowledge of the different types of MAOIs and when to use them in the management of depression
  • Recognise absolute and relative contraindications for the use of MAOIs and TCAs
  • Learn effective strategies for initiating treatment with MAOIs and managing their side effects
  • Understand the augmentation options available for patients taking MAOIs

Course Programme


1 Unit | 1.5 hours total length

  • Video: Mastering the Classics With Dr Gillman - Unlocking the Potential of MAOIs and TCAs in Modern Psychiatry

Course Description


Unlocking the Potential of MAOI Antidepressants and TCA Antidepressants in Modern Psychiatry

This course is designed to broaden your understanding of MAOIs and TCAs in modern psychiatry practice. This comprehensive program will enhance your clinical application of vital therapeutic alternatives within the realm of Major Depressive Disorder management.

While newer antidepressant medications may have gained popularity over the years, TCA antidepressants and MAOI antidepressants remain vital to psychiatric care. Members will explore topics such as the MAOI mechanism of action, the types of MAOIs, and a MAOI drug list. Participants will explore how MAOIs work compared to other medications, and absolute and relative contraindications for their use.

Other key topics include identifying patients suitable for TCAs, tricyclic antidepressants’ mechanism of action, and when to initiate TCA and MAOI treatment. SSRI, SNRI, TCA and MAOI distinctive features will be discussed, as well as an analysis of MAOIs vs. SSRIs and other antidepressants.

We will also cover effective management of side effects of MAOI antidepressants and TCA antidepressants ,and augmentation options for patients taking MAOIs. This will round out your educational experience and enable you in harnessing the full potential of these medications in your practice.

This course is an indispensable resource for any mental health professional seeking to enhance their expertise in the use of MAOI antidepressants and TCAs in treating depression.

 

Related Courses

Enhance your knowledge and application of MAOIs and TCAs. Explore the appropriate use, management, side effects, and contraindications of MAOI antidepressants.

Course Information

  • 1.5 hours
  • 1.5 CPD

Inclusions

  • 1.5 hours of video
  • Certificate of Completion

Material Downloads

  • certificate

Instructors

ken gillman Dr. Ken Gillman Speaker | Chairman of International MAOI Expert Group

Dr. Ken Gillman is a world-renowned researcher and authority in the field of psychiatry, with a focus on serotonin toxicity, monoamine oxidase inhibitor (MAOI) antidepressant drugs, and related topics. He is currently the Principal Investigator and Director at PsychoTropical Research, where he leads a team of experts who publish papers in his areas of specialization in the peer-reviewed scientific literature.

Dr. Gillman’s research contributions have earned him an impressive H-index of 29 and a cumulative total of more than 4,500 citations. He has authored approximately fifteen major single-author review papers that have been extensively cited (between 100-500 times).

As the founder and convener of the International MAOI Expert Group and the Chairman of its presiding council, Dr. Gillman has played a pivotal role in advancing the understanding and clinical application of MAOIs in psychiatry. He is also an invited expert participant in the Malignant Hyperthermia Association of the US (MHAUS) expert group.

With his vast expertise and groundbreaking research contributions, Dr. Gillman is highly regarded as a thought leader and innovator in the field of psychiatry. His insights and perspectives are sure to enrich any discussion and deepen our understanding of the clinical application of MAOIs and TCAs in modern psychiatry practice.


Sanil Rege Dr. Sanil Rege Course Host | MBBS, MRCPsych, FRANZCP

Dr. Sanil Rege is a consultant psychiatrist and academic with dual qualifications from the UK and Australia. He is a Fellow of the Royal Australian and New Zealand College of Psychiatrists and a Member of the Royal College of Psychiatrists (UK).

Get Course Access

Get instant access

Pick your preferred way of learning and redefine your psychiatry learning journey.

Subscribe to The Academy

$599
AUD

  • Instant access to all courses for 1 year
  • 50+ hours of learning, updated regularly
  • Earn CME/CE/CPD points
  • Download CPD certificates
  • Interactive, cutting-edge courses
  • Case studies, quizzes, multimedia
  • Track your CPD points
Best Offer